IMFINZI (Durvalumab) 120 mg Injection
IMFINZI Durvalumab 120 mg Injection is an advanced cancer immunotherapy medicine used in modern oncology care. It contains Durvalumab, a programmed death-ligand 1 (PD-L1) blocking antibody that helps the immune system recognize and destroy cancer cells more effectively. It is widely used in cancers such as non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and certain biliary tract cancers, often as maintenance or combination therapy after chemotherapy or radiotherapy.
This medicine belongs to immune checkpoint inhibitor therapy, designed to enhance the body’s natural immune response against cancer progression.
Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
Composition and Content
- Active Ingredient: Durvalumab
- Strength: 120 mg per vial
- Dosage Form: Intravenous (IV) infusion
- Drug Class: Immune checkpoint inhibitor (PD-L1 monoclonal antibody)
How It Works
IMFINZI works by:
- Blocking PD-L1 proteins on cancer cells
- Reactivating T-cell immune response
- Helping immune system detect and attack tumors
- Slowing cancer growth and preventing progression
Uses and Treatments
IMFINZI (Durvalumab) 120 mg Injection is used for:
- Non-Small Cell Lung Cancer (NSCLC)
- Extensive Stage Small Cell Lung Cancer (SCLC)
- Biliary Tract Cancer
- Bladder and urothelial cancers (selected cases)
- Maintenance therapy after chemoradiation
Dosage and How to Use
- Given as intravenous infusion only in hospitals/clinics
- Administered every 2–4 weeks depending on treatment protocol
- Dose is determined by oncologist based on weight and condition
- Must be used strictly under medical supervision
Advantages of IMFINZI (Durvalumab)
- Strengthens immune system to fight cancer
- Improves survival in certain advanced cancers
- Used as maintenance therapy after chemotherapy/radiotherapy
- Targeted immunotherapy with precise action
- Helps delay cancer progression and recurrence
Storage Conditions
- Store at 2°C to 8°C (refrigerated)
- Do not freeze
- Keep in original carton to protect from light
- Do not shake vial
- For hospital/oncology use only
Alternative Indian Brands / Options
Durvalumab is a patented immunotherapy, so no direct Indian generic equivalent exists. However, similar immune checkpoint inhibitors used in oncology include:
- Keytruda (Pembrolizumab) by Merck & Co.
- Opdivo (Nivolumab) by Bristol Myers Squibb
- Tecentriq (Atezolizumab) by Roche
- Oncology biosimilars and supportive therapies from Dr. Reddy’s Laboratories
All alternatives must be selected only under oncologist supervision.
Buy IMFINZI Durvalumab 120 mg Injection Online in the United States – Trusted Oncology Medicine Exporter
Looking to buy IMFINZI Durvalumab 120 mg Injection in the United States of America? GlobMedIndia is a trusted international medicine exporter of oncology and immunotherapy drugs, offering safe, genuine, and high-quality cancer medicines with secure global delivery across United States.
We supply advanced immunotherapy medicines used in modern cancer treatment protocols with strict pharmaceutical quality standards and reliable global logistics.
Coverage includes major US cities such as:
California, Washington, Chicago, Los Angeles, Houston, Phoenix, Austin, Columbus, Philadelphia, San Antonio, San Diego, Dallas, and Jacksonville.
Why Choose GlobMedIndia?
- Trusted exporter of oncology medicines
- Fast and secure international delivery
- 100% genuine pharmaceutical products
- Reliable global healthcare supply network
- Expert support for hospital procurement
- Buy Durvalumab 120 mg USA
- IMFINZI injection price USA
- Lung cancer immunotherapy USA
- PD-L1 inhibitor medicine USA
- Cancer immunotherapy injection USA
- Oncology medicine exporter USA
- GlobMedIndia cancer drugs
👉 Order Now for Fast, Safe & Secure Delivery Across the United States!
